Actinium Pharmaceuticals, Inc.
Targeted Therapies for Patients with Unmet Needs
58 employees · est. 2000 · New York, United States
TransCode Therapeutics, Inc.
Delivering a cancer-free future
11 employees · est. 2016 · Newton, United States
Actinium Pharmaceuticals, Inc. is the older company (2000 vs 2016); Actinium Pharmaceuticals, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Actinium Pharmaceuticals, Inc. | TransCode Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2016 |
| Headquarters | ||
| Headquarters | New York, United States | Newton, United States |
| Employees | ||
| Employees | 58 larger | 11 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Grant | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $28.05M |
| Funding Rounds | ||
| Funding Rounds | 1 | 10 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Actinium Pharmaceuticals, NYSE: ATNM, Targeted Radioimmunotherapies, Advanced Cancers, AML, BMT Myeloablation, Hematopoeitic Stem Cell, Bone Marrow Transplant, Biopharmaceuticals, ADCs, Acute Myeloid Leukemia, Multiple Myeloma | Cancer Therapeutics, Targeted Therapies, Biomarker Targeting, RNA-based Therapies, Gene Therapy, Oncology Research, Drug Delivery Technology, MicroRNA-10b, PD-L1 Modulation, CRISPR/Cas9, Cancer Vaccine Development, Tumor Microenvironment, Cancer Treatment Innovation, Precision Medicine, Immunotherapy |
| Website | ||
| Website | actiniumpharma.com | transcodetherapeutics.com |
About Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) is a biotechnology and pharmaceutical company based in the United States, founded in 2000. The company's mission is to develop innovative targeted radioimmunotherapies to address the unmet needs of patients with advanced cancers. Actinium Pharmaceuticals i...
About TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and efficient delivery of targeted therapeutics, particularly TTX-MC138, which targets microRNA-10b, consider...
We will tell you when either one moves
BounceWatch watches Actinium Pharmaceuticals, Inc. and TransCode Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Actinium Pharmaceutica... and TransCode Therapeutics... — by email.
Frequently Asked Questions
Compare Actinium Pharmaceuticals, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Actinium Pharmaceuticals, Inc. on 9 Jun 2026, and TransCode Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.